EPITA encourages applications from either diabetes physicians or nephrologists with an interest in Beta Cell Replacement Therapy or transplant surgeons.
Category: General
ESOT TLJ 3.0: Setting the Stage for a Rigorous, Regularly Updated Development Process
NEWLY PUBLISHED: 𝗘𝗦𝗢𝗧 𝗖𝗼𝗻𝘀𝗲𝗻𝘀𝘂𝘀 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝗳𝗼𝗿 𝗢𝗿𝗴𝗮𝗻 𝗧𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁𝗮𝘁𝗶𝗼𝗻: 𝗦𝗲𝘁𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗦𝘁𝗮𝗴𝗲 𝗳𝗼𝗿 𝗮 𝗥𝗶𝗴𝗼𝗿𝗼𝘂𝘀, 𝗥𝗲𝗴𝘂𝗹𝗮𝗿𝗹𝘆 𝗨𝗽𝗱𝗮𝘁𝗲𝗱 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗣𝗿𝗼𝗰𝗲𝘀𝘀
Professional development workshop: “How to best plan your career: Tips and tricks from the experts”
This series will provide expert advice and practical tips to support the personal and professional development of transplant professionals at all career stages. The topics of this series were selected based on the results of an educational needs assessment recently conducted by ESOT.
About EF CLIF
The European Foundation for the Study of Chronic Liver Failure (EF CLIF) is a private non-profit organization connecting biomedical researchers and healthcare professionals with each other, with patients and patient associations, and with society. The fundamental purpose of EF CLIF, reflected in its founding Statements of 2015, is to advance knowledge and promote research and
The European Medicines Agency (EMA) announcements
ESOT would like to share two recent transplant-related announcements made by the EMA. EMA consultation: iBox Scoring System in kidney transplant patients The EMA has published for public consultation a “draft qualification opinion for the iBox Scoring System as a secondary efficacy endpoint in clinical trials investigating novel immunosuppressive medicines in kidney transplant patients”.
ETAHP Call for Nominations
The European Transplant Allied Healthcare Professionals (ETAHP) – would like to announce a call for nominations for two new Board members. All ESOT/ETAHP affiliates are welcome to send nominations for these positions. You may nominate yourself or a colleague. The new ETAHP Board Members will hold office for 4 years (2022-2026), starting December 2022. In
Info Session on the ESOT Mentorship Programme!
Do you want to learn more on the ESOT Mentorship Programme before applying either as mentors or mentees? Do you have any doubts on this new opportunity for professional development? Join us at the Info Session on Tuesday 18 October at 18:30 CEST! Luca Toti, Chair of the Education Committee, and Liset Pengel, Vice-Chair, will
CareDx’s AlloSeq cfDNA Represents a Minimally Invasive, Accurate Method to Detect Graft Injury as a Leading Solution for Transplant Patient Management in Europe
CareDx has developed AlloSeq cfDNA, a targeted NGS assay that relies on 202 single-nucleotide polymorphisms (SNPs) located throughout the genome to measure the dd-cfDNA in transplant recipients. The assay was designed to be fully compatible with any clinical laboratory setup and combines a streamlined workflow with a fully automated analysis software to accurately quantify dd-cfDNA in transplant recipients.
ESOT Mentorship Programme: A major opportunity for professional development
ESOT is strongly committed to principles of equity, diversity and inclusion and strives to promote such values through its education programme. Members of traditionally underrepresented and marginalized groups are particularly encouraged to apply both as mentors and as mentees.
Learn about the latest developments in regenerative medicine on Transplant Live
A new course on Regenerative medicine, created by Martin Hoogduijn (Rotterdam, The Netherlands), Hanne Scholz (Oslo, Norway), and Olivier Thaunat (Lyon, France), is now available on Transplant Live, the ESOT online education platform!